Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease
Authors
Keywords
Enhanced Liver fibrosis (ELF), Fibroscan, |NAFLD, Cirrhosis detection, Cost savings
Journal
BMC GASTROENTEROLOGY
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-11
DOI
10.1186/s12876-019-1039-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease
- (2019) Ankur Srivastava et al. JOURNAL OF HEPATOLOGY
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- Guidelines on the management of abnormal liver blood tests
- (2017) Philip N Newsome et al. GUT
- Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score
- (2016) Elliot B. Tapper et al. PLoS One
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation
- (2015) Catriona Crossan et al. HEALTH TECHNOLOGY ASSESSMENT
- Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
- (2015) Zobair M. Younossi et al. HEPATOLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- P1046 : A one year retrospective review of new patient attendances at a tertiary hepatology centre highlighting the increasing challenge of NAFLD and the need to develop clinical pathways
- (2015) A. Srivastava et al. JOURNAL OF HEPATOLOGY
- Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography
- (2015) D. J. Harman et al. BMJ Open
- Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis
- (2014) Roger Williams et al. LANCET
- Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
- (2014) Amit G. Singal et al. PLOS MEDICINE
- Understanding Sources of Bias in Diagnostic Accuracy Studies
- (2013) Robert L. Schmidt et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
- (2013) Raluca Pais et al. JOURNAL OF HEPATOLOGY
- 1 and 5 year survival estimates for people with cirrhosis of the liver in England, 1998–2009: A large population study
- (2013) Sonia Ratib et al. JOURNAL OF HEPATOLOGY
- Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)
- (2013) Siddharth Verma et al. LIVER INTERNATIONAL
- Effectiveness of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis
- (2012) A. G. Singal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The Relevance of Liver Histology to Predicting Clinically Meaningful Outcomes in Nonalcoholic Steatohepatitis
- (2012) Mangesh R. Pagadala et al. Clinics in Liver Disease
- Pioglitazone and vitamin E for nonalcoholic steatohepatitis: A cost utility analysis
- (2012) Suzanne E. Mahady et al. HEPATOLOGY
- Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
- (2011) G. Vernon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study
- (2011) Neeraj Bhala et al. HEPATOLOGY
- Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease
- (2011) Srinevas K. Reddy et al. HEPATOLOGY
- Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort
- (2011) Matthew J. Armstrong et al. JOURNAL OF HEPATOLOGY
- Dropping the Baton: Specialty Referrals in the United States
- (2011) ATEEV MEHROTRA et al. MILBANK QUARTERLY
- The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study
- (2010) K. M. Fleming et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
- (2010) S. McPherson et al. GUT
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
- (2010) Mustafa S. Ascha et al. HEPATOLOGY
- Review: Treatment options for nonalcoholic fatty liver disease
- (2010) Brian Lam et al. Therapeutic Advances in Gastroenterology
- Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease
- (2009) Vincent Wai-Sun Wong et al. HEPATOLOGY
- Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms
- (2009) Giada Sebastiani WORLD JOURNAL OF GASTROENTEROLOGY
- Spectrum bias--why clinicians need to be cautious when applying diagnostic test studies
- (2008) B. H Willis FAMILY PRACTICE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now